1. Home
  2. SWBI vs CGEM Comparison

SWBI vs CGEM Comparison

Compare SWBI & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWBI
  • CGEM
  • Stock Information
  • Founded
  • SWBI 1852
  • CGEM 2016
  • Country
  • SWBI United States
  • CGEM United States
  • Employees
  • SWBI N/A
  • CGEM N/A
  • Industry
  • SWBI Ordnance And Accessories
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWBI Industrials
  • CGEM Health Care
  • Exchange
  • SWBI Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • SWBI 453.6M
  • CGEM 437.2M
  • IPO Year
  • SWBI N/A
  • CGEM 2021
  • Fundamental
  • Price
  • SWBI $8.53
  • CGEM $9.78
  • Analyst Decision
  • SWBI Buy
  • CGEM Strong Buy
  • Analyst Count
  • SWBI 2
  • CGEM 7
  • Target Price
  • SWBI $12.00
  • CGEM $26.29
  • AVG Volume (30 Days)
  • SWBI 474.5K
  • CGEM 881.9K
  • Earning Date
  • SWBI 12-05-2025
  • CGEM 11-06-2025
  • Dividend Yield
  • SWBI 6.35%
  • CGEM N/A
  • EPS Growth
  • SWBI N/A
  • CGEM N/A
  • EPS
  • SWBI 0.26
  • CGEM N/A
  • Revenue
  • SWBI $471,404,000.00
  • CGEM N/A
  • Revenue This Year
  • SWBI N/A
  • CGEM N/A
  • Revenue Next Year
  • SWBI $3.56
  • CGEM N/A
  • P/E Ratio
  • SWBI $32.38
  • CGEM N/A
  • Revenue Growth
  • SWBI N/A
  • CGEM N/A
  • 52 Week Low
  • SWBI $7.73
  • CGEM $5.68
  • 52 Week High
  • SWBI $14.20
  • CGEM $13.78
  • Technical
  • Relative Strength Index (RSI)
  • SWBI 38.46
  • CGEM 66.87
  • Support Level
  • SWBI $8.14
  • CGEM $8.23
  • Resistance Level
  • SWBI $8.47
  • CGEM $9.10
  • Average True Range (ATR)
  • SWBI 0.28
  • CGEM 0.67
  • MACD
  • SWBI -0.05
  • CGEM 0.11
  • Stochastic Oscillator
  • SWBI 26.99
  • CGEM 85.45

About SWBI Smith & Wesson Brands Inc.

Smith & Wesson Brands Inc is a U.S.-based leader in firearm manufacturing. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The firm's brand portfolio consists of Smith and Wesson, M&P, Thompson/Center Arms, Performance Center, and Gemtech; which are used for defense, law enforcement, hunting, and sporting purposes. The company operates internationally, with the majority of income generated by the U.S. market from its handgun products.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: